Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cell

Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cell

US Patent 11786552 · Granted Oct 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Water-based electronic cigarette liquid2025
Degradable regenerative medical material for promoting tissue in-situ regenerati2025
Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and u2025
Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and u2025
H3.3 CTL peptides and uses thereof2024
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and us2023
Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and us2023
Simulation device for characterizing aerodynamics of dry power inhalants in resp2022